BioCardia logo
BioCardia BCDA
$ 1.19 2.59%

Annual report 2025
added 03-24-2026

report update icon

BioCardia DSO Ratio 2011-2026 | BCDA

Annual DSO Ratio BioCardia

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - 101 47 68.1 - 75.6 160 72.4 46.9 - - - - 2.04 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
2.04 K 46.9 326

Quarterly DSO Ratio BioCardia

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - - 1.03 K 100 - 28 284 252 - 110 25.1 360 - 23.7 277 419 - 623 784 455 - 69.1 156 88.9 - 298 105 84.6 - 66.7 77.4 56.3 - 57.7 46.9 46.4 - - - - - - - - - - - - - 115 129 377 - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.03 K 23.7 226

DSO Ratio of other stocks in the Biotechnology industry

Issuer DSO Ratio Price % 24h Market Cap Country
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
70.9 $ 21.87 2.15 % $ 1.02 B usaUSA
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
20.6 $ 0.9 - $ 6.62 M chinaChina
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
37.5 $ 22.28 1.46 % $ 3.69 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
146 - 5.93 % $ 314 M canadaCanada
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
Aravive Aravive
ARAV
16.8 - -13.39 % $ 1.45 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
59 - 17.91 % $ 11.1 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.114 - - $ 26.5 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
103 $ 4.1 0.37 % $ 438 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
106 $ 23.98 3.07 % $ 3.05 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
58.2 $ 1.47 1.74 % $ 391 M britainBritain
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
28.1 $ 2.98 2.41 % $ 4.91 M israelIsrael
BioDelivery Sciences International BioDelivery Sciences International
BDSI
115 - -4.8 % $ 255 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
CureVac N.V. CureVac N.V.
CVAC
13.6 - - $ 867 M germanyGermany
bluebird bio bluebird bio
BLUE
2.47 - - $ 546 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
294 $ 1.72 - $ 115 M usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
103 $ 1.1 3.76 % $ 13.4 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
52.4 - -3.03 % $ 260 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
87.4 - - $ 35.4 M usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
182 - - $ 3.45 B usaUSA